Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8a6674d7e43c80dc2748901439842570 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-48 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-23 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 |
filingDate |
2002-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2008-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5233b05b9fb7aa5ff1224e3f30aa729 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b113652da54c4a8d63830e374a8c9bb |
publicationDate |
2008-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
RU-2314121-C2 |
titleOfInvention |
Method for treatment or prophylaxis of obesity |
abstract |
FIELD: medicine, pharmacy. n SUBSTANCE: invention relates to producing medicinal agents and to a method for treatment of obesity. For production of medicinal agents amyline or amyline agonists of the definite chemical structure are used. Except for, invention proposes a method for treatment of obesity with using the specific amyline agonist - 25,28,29 Pro-h-amyline in the developed for its doses and regimens of administration. Invention provides expanding assortment of medicinal agents used in treatment of obesity. n EFFECT: improved method of treatment. n 11 cl, 8 tbl, 10 ex |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2552221-C2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2523558-C2 |
priorityDate |
1997-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |